Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection
- PMID: 2180821
- PMCID: PMC258592
- DOI: 10.1128/iai.58.4.1120-1123.1990
Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection
Abstract
Proteus mirabilis, a urease-producing uropathogen, causes serious urinary tract infections in humans. To specifically evaluate the contribution of urease to virulence, a mutation was introduced into P. mirabilis HI4320 by homologous recombination. Virulence was assessed in the CBA mouse model of ascending urinary tract infection. Twenty mice each were challenged transurethrally with P. mirabilis HI4320 and its urease-negative derivative (1 x 10(9) to 2 x 10(9) CFU). At 48 h animals were sacrificed and the mean log10 CFU per milliliter of urine (parent, 6.23; mutant, 4.19; P = 0.0014) or per gram of bladder (parent, 6.29; mutant, 4.28; P = 0.0002), left kidney (parent, 4.11; mutant, 1.02; P = 0.00009), and right kidney (parent, 4.11; mutant, 2.43; P = 0.036) were all shown to be significantly different. These data demonstrate a role for urease as a critical virulence determinant for uropathogenic P. mirabilis.
Similar articles
-
Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.Infect Immun. 1993 Jul;61(7):2748-54. doi: 10.1128/iai.61.7.2748-2754.1993. Infect Immun. 1993. PMID: 8514376 Free PMC article.
-
UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections.Infect Immun. 2003 Feb;71(2):1026-30. doi: 10.1128/IAI.71.2.1026-1030.2003. Infect Immun. 2003. PMID: 12540589 Free PMC article.
-
Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection.Infect Immun. 1994 Feb;62(2):536-42. doi: 10.1128/iai.62.2.536-542.1994. Infect Immun. 1994. PMID: 7905463 Free PMC article.
-
Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.Kidney Int Suppl. 1994 Nov;47:S129-36. Kidney Int Suppl. 1994. PMID: 7869662 Review.
-
Vaccines for Proteus mirabilis in urinary tract infection.Int J Antimicrob Agents. 2002 Jun;19(6):461-5. doi: 10.1016/s0924-8579(02)00102-4. Int J Antimicrob Agents. 2002. PMID: 12135833 Review.
Cited by
-
Structure of the UreD-UreF-UreG-UreE complex in Helicobacter pylori: a model study.J Biol Inorg Chem. 2013 Jun;18(5):571-7. doi: 10.1007/s00775-013-1002-8. Epub 2013 May 10. J Biol Inorg Chem. 2013. PMID: 23661161
-
Insertional inactivation of an Escherichia coli urease gene by IS3411.J Bacteriol. 1992 Feb;174(3):883-8. doi: 10.1128/jb.174.3.883-888.1992. J Bacteriol. 1992. PMID: 1310093 Free PMC article.
-
Second-Generation Escherichia coli SuptoxR Strains for High-Level Recombinant Membrane Protein Production.ACS Synth Biol. 2022 Aug 19;11(8):2599-2609. doi: 10.1021/acssynbio.1c00598. Epub 2022 Aug 3. ACS Synth Biol. 2022. PMID: 35922033 Free PMC article.
-
Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.Clin Microbiol Rev. 2008 Jan;21(1):26-59. doi: 10.1128/CMR.00019-07. Clin Microbiol Rev. 2008. PMID: 18202436 Free PMC article. Review.
-
Ynt is the primary nickel import system used by Proteus mirabilis and specifically contributes to fitness by supplying nickel for urease activity.Mol Microbiol. 2020 Aug;114(2):185-199. doi: 10.1111/mmi.14505. Epub 2020 Apr 19. Mol Microbiol. 2020. PMID: 32255226 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical